Astragaloside Alleviates Hepatic Fibrosis Function via PAR2 Signaling Pathway in Diabetic Rats

Astragaloside Alleviates Hepatic Fibrosis Function via PAR2 Signaling Pathway in Diabetic Rats

Background/Aims: Astragaloside (AGS) extracted from radix astragalin (Huangqi) has been considered to be beneficial to liver diseases. In this study, we examined the role played by AGS in alleviating hepatic fibrosis function via protease-activated receptor-2 (PAR2) mechanisms. We hypothesized that...

Full description

Bibliographic Details
Main Authors: Zhenchang Wang, Quanqiang Li, Mingpeng Xiang, Fengying Zhang, Dongyu Wei, Zhixi Wen, Ying Zhou
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-02-01
Series:Cellular Physiology and Biochemistry
Subjects:
Hepatic fibrosis
Diabetes
PAR2
PAK
PKC
Astragaloside
Online Access:http://www.karger.com/Article/FullText/464122

Internet

http://www.karger.com/Article/FullText/464122

Similar Items